For instance, nintedanib was found to decrease cellular proliferation of MPNST and SS cell lines, both of which express relatively high levels of PDGFR and FGFR RTKs [64,118]. This evidence concerns the gene PDGFRB and malignant peripheral nerve sheath tumor.